Intermediate for Idelalisib. Idelalisib (trade name Zydelig) is a phosphoinositide 3-kinase inhibitor for the treatment of certain hematological malignancies. Idelalisib has been approved by the U.S Food and Drug Administration on July 23, 2014.
Product Name: 2-Fluoro-6-nitro-N-phenylbenzamide
CAS Number: 870281-83-7
Molecular Weight:  260.2241
Molecular Formula:  C13H9FN2O3
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.